Although no significant differences were clearly observed, tumors of the mice treated with anti-ILT2 were, nevertheless, smaller than in untreated mice, suggesting a blocking effect on the anti-tumor capacity of HLA-G. The gene discussed is LILRB1; the disease is neoplasm.